{"url":"https://nivawealth.com/firms/deerfield-management-157876","iapdUrl":"https://adviserinfo.sec.gov/firm/summary/157876","regulatoryAum":19084042235,"crd":"157876","secFileNumber":"801-73284","legalName":"Deerfield Management Company, L.P.","displayName":"Deerfield Management","website":"https://www.deerfield.com","linkedinUrl":"https://www.linkedin.com/company/deerfield-management","founded":null,"organization":"Delaware limited partnership","fiscalYearEnd":"December","headquarters":{"street":"345 Park Avenue South, 12th Floor","city":"New York","state":"NY","stateName":"New York","country":"United States","postalCode":"10010"},"tradeNames":["Deerfield Discovery and Development (3DC)","Deerfield Intelligence"],"registration":{"secApproved":"30 March 2012","noticeFilings":null,"latestNoticeFiling":null},"staff":{"employees":189,"advisory":89,"brokerDealerReps":0,"insuranceAgents":0,"promoters":0},"aum":{"discretionary":19084042235,"discretionaryAccounts":12,"nonDiscretionary":0,"nonDiscretionaryAccounts":0,"wrapProgram":null,"nonUsClientsPct":25,"nonAumClients":0},"clientTypes":[{"label":"Pooled investment vehicles","clients":12,"regulatoryAum":19084042235}],"fees":[],"feeNotes":[],"feePrograms":[],"brochureCoverage":{"scope":"known_documents","status":"not_processed","checkedAt":null,"documents":[]},"custodians":[],"custodyNote":"Deerfield Management has custody of $19.08B for 12 clients.","otherCustodians":[],"leadership":[{"name":"James Flynn","title":"President","crd":"2743396"},{"name":"Jonathan Isler","title":"Chief Financial Officer, Funds","crd":"6103527"},{"name":"Bryan Sendrowski","title":"Chief Financial Officer","crd":"7719267"},{"name":"Robert Snetiker","title":"General Counsel and Chief Compliance Officer","crd":"7754375"}],"ownership":[{"label":"Deerfield Manager Holdings, LP","detail":"Limited partner in the 75% or more ownership band and a control person, since June 2025."},{"label":"James Flynn","detail":"Indirect owner: a limited partner of Deerfield Manager Holdings, LP in the 25% to 50% band and a control person, since June 2025. Also manager of Deerfield Ugp, LLC and a control person, since June 2025.","parent":"Deerfield Manager Holdings, LP"},{"label":"Deerfield Ugp, LLC","detail":"Indirect owner: general partner of Deerfield Manager Holdings, LP and a control person, since June 2025.","parent":"Deerfield Manager Holdings, LP"}],"branchOffices":null,"filedOffices":{"otherThanPrincipal":1,"privateResidences":0},"listedOfficeAddresses":2,"officesByState":[{"state":"New Jersey","offices":1,"addresses":[{"street":"300 Interpace Parkway (C3)","city":"Parsippany"}]},{"state":"New York","offices":1,"addresses":[{"street":"345 Park Avenue South, 12th Floor","city":"New York","headquarters":true}]}],"advFacts":{"source":{"file":"ia100226.zip","asOf":"2 October 2026"},"telephone":"212-551-1600","stateRegisteredReps":0,"otherAdviserReps":0,"compensation":["A percentage of assets under management","Performance-based fees"],"activities":["Portfolio management for pooled investment vehicles (other than investment companies)"],"financialPlanningClients":null,"assetMix":[],"privateFunds":12},"sources":{"adv1FilingDate":"31 July 2026","adv1Url":"https://reports.adviserinfo.sec.gov/reports/ADV/157876/PDF/157876.pdf","brochureDate":null,"brochureUrl":null,"iapdCompiledDate":null,"retrievedDate":"15 October 2026","retrievedOn":"2026-10-15","adv1Pages":{},"brochurePages":{}},"otherBusiness":[],"faq":[{"question":"How many clients does Deerfield Management have?","answer":"Deerfield Management has 12 clients and manages $19.1 billion for them, as of July 2026.","source":"Form ADV Part 1A, Items 5.D and 5.F, filed 31 July 2026","sourceRef":{"doc":"adv1","section":"employees"}},{"question":"What services does Deerfield Management offer?","answer":"Deerfield Management provides portfolio management for pooled vehicles.","source":"Form ADV Part 1A, Item 5.G, from the SEC's 2 October 2026 data file","sourceRef":{"doc":"adv1","section":"employees"}},{"question":"How many financial advisors does Deerfield Management have?","answer":"Deerfield Management has 0 investment adviser representatives registered with state securities authorities, out of 189 employees, and 89 perform investment advisory functions. None are registered representatives of a broker-dealer or licensed insurance agents.","source":"Form ADV Part 1A, Items 5.A and 5.B, from the SEC's 2 October 2026 data file","sourceRef":{"doc":"adv1","section":"employees"}},{"question":"Who owns Deerfield Management?","answer":"Deerfield Management is owned through a holding company by James Flynn. Its direct owner is Deerfield Manager Holdings, LP (75% or more).","source":"Form ADV Part 1A, Schedules A and B, filed 31 July 2026","sourceRef":{"doc":"adv1","section":"scheduleA"}},{"question":"How does Deerfield Management get paid?","answer":"Deerfield Management is paid through a percentage of assets under management and performance-based fees. Its Form ADV lists no commissions among how it is paid.","source":"Form ADV Part 1A, Item 5.E, from the SEC's 2 October 2026 data file","sourceRef":{"doc":"adv1","section":"employees"}}],"holdings":{"url":"https://nivawealth.com/firms/deerfield-management-157876/holdings","form":"13F-HR","periodOfReport":"2026-06-30","filedOn":"2026-08-14","filingIndexUrl":"https://www.sec.gov/Archives/edgar/data/1009258/000121390026089991/0001213900-26-089991-index.html","totalValue":9586027944,"positionCount":82,"top10Share":0.5316802187281419,"top10":[{"issuer":"NUVALENT INC","titleOfClass":"COM","cusip":"670703107","value":2130183575,"shares":17248450,"shareType":"SH","priorValue":1767103703,"priorShares":17248450},{"issuer":"BROOKDALE SR LIVING INC","titleOfClass":"NOTE   3.500%10/1","cusip":"112463AF1","value":585704753,"shares":306885000,"shareType":"PRN","priorValue":505441129,"priorShares":306885000},{"issuer":"REVOLUTION MEDICINES INC","titleOfClass":"COM","cusip":"76155X100","value":447973760,"shares":2392000,"shareType":"SH","priorValue":223383250,"priorShares":2297000},{"issuer":"PRAXIS PRECISION MEDICINES I","titleOfClass":"COM NEW","cusip":"74006W207","value":322520281,"shares":963351,"shareType":"SH","priorValue":310382059,"priorShares":963351},{"issuer":"VIATRIS INC","titleOfClass":"COM","cusip":"92556V106","value":320873980,"shares":20206170,"shareType":"SH","priorValue":272985357,"priorShares":20206170},{"issuer":"CENTENE CORP DEL","titleOfClass":"COM","cusip":"15135B101","value":314595190,"shares":4901000,"shareType":"SH","priorValue":193725559,"priorShares":5917091},{"issuer":"REVOLUTION MEDICINES INC","titleOfClass":"NOTE 0.500% 5/0","cusip":"76155XAA8","value":251681000,"shares":200000000,"shareType":"PRN"},{"issuer":"UNITED THERAPEUTICS CORP DEL","titleOfClass":"COM","cusip":"91307C102","value":247616310,"shares":457000,"shareType":"SH","priorValue":270991860,"priorShares":457000},{"issuer":"ARROWHEAD PHARMACEUTICALS IN","titleOfClass":"NOTE           1/1","cusip":"04280AAC4","value":240537600,"shares":200000000,"shareType":"PRN","priorValue":207181800,"priorShares":200000000},{"issuer":"LEGEND BIOTECH CORP","titleOfClass":"SPONSORED ADS","cusip":"52490G102","value":235014985,"shares":8137638,"shareType":"SH","priorValue":139069371,"priorShares":7687638}],"positionsListed":82,"positions":[{"issuer":"NUVALENT INC","titleOfClass":"COM","cusip":"670703107","value":2130183575,"shares":17248450,"shareType":"SH","priorValue":1767103703,"priorShares":17248450},{"issuer":"BROOKDALE SR LIVING INC","titleOfClass":"NOTE   3.500%10/1","cusip":"112463AF1","value":585704753,"shares":306885000,"shareType":"PRN","priorValue":505441129,"priorShares":306885000},{"issuer":"REVOLUTION MEDICINES INC","titleOfClass":"COM","cusip":"76155X100","value":447973760,"shares":2392000,"shareType":"SH","priorValue":223383250,"priorShares":2297000},{"issuer":"PRAXIS PRECISION MEDICINES I","titleOfClass":"COM NEW","cusip":"74006W207","value":322520281,"shares":963351,"shareType":"SH","priorValue":310382059,"priorShares":963351},{"issuer":"VIATRIS INC","titleOfClass":"COM","cusip":"92556V106","value":320873980,"shares":20206170,"shareType":"SH","priorValue":272985357,"priorShares":20206170},{"issuer":"CENTENE CORP DEL","titleOfClass":"COM","cusip":"15135B101","value":314595190,"shares":4901000,"shareType":"SH","priorValue":193725559,"priorShares":5917091},{"issuer":"REVOLUTION MEDICINES INC","titleOfClass":"NOTE 0.500% 5/0","cusip":"76155XAA8","value":251681000,"shares":200000000,"shareType":"PRN"},{"issuer":"UNITED THERAPEUTICS CORP DEL","titleOfClass":"COM","cusip":"91307C102","value":247616310,"shares":457000,"shareType":"SH","priorValue":270991860,"priorShares":457000},{"issuer":"ARROWHEAD PHARMACEUTICALS IN","titleOfClass":"NOTE           1/1","cusip":"04280AAC4","value":240537600,"shares":200000000,"shareType":"PRN","priorValue":207181800,"priorShares":200000000},{"issuer":"LEGEND BIOTECH CORP","titleOfClass":"SPONSORED ADS","cusip":"52490G102","value":235014985,"shares":8137638,"shareType":"SH","priorValue":139069371,"priorShares":7687638},{"issuer":"COGENT BIOSCIENCES INC","titleOfClass":"COM","cusip":"19240Q201","value":193736225,"shares":5006104,"shareType":"SH","priorValue":348099826,"priorShares":9043903},{"issuer":"GENMAB A/S","titleOfClass":"SPONSORED ADS","cusip":"372303206","value":188581550,"shares":6865000,"shareType":"SH","priorValue":66055460,"priorShares":2462000},{"issuer":"BROOKDALE SR LIVING INC","titleOfClass":"COM","cusip":"112463104","value":187239845,"shares":11637032,"shareType":"SH","priorValue":159194598,"priorShares":11637032},{"issuer":"VERA THERAPEUTICS INC","titleOfClass":"CL A","cusip":"92337R101","value":168052724,"shares":3916400,"shareType":"SH","priorValue":149740083,"priorShares":3722100},{"issuer":"IONIS PHARMACEUTICALS INC","titleOfClass":"COM","cusip":"462222100","value":156967955,"shares":1979669,"shareType":"SH","priorValue":148653345,"priorShares":1979669},{"issuer":"CELCUITY INC","titleOfClass":"COM","cusip":"15102K100","value":151805085,"shares":1451014,"shareType":"SH","priorValue":195635960,"priorShares":1714000},{"issuer":"BIOCRYST PHARMACEUTICALS INC","titleOfClass":"COM","cusip":"09058V103","value":150964030,"shares":15096403,"shareType":"SH","priorValue":143161760,"priorShares":15038000},{"issuer":"NEWAMSTERDAM PHARMA COMPANY","titleOfClass":"ORDINARY SHARES","cusip":"N62509109","value":144533699,"shares":4264789,"shareType":"SH","priorValue":136515896,"priorShares":4264789},{"issuer":"ACADIA HEALTHCARE COMPANY IN","titleOfClass":"COM","cusip":"00404A109","value":133475600,"shares":4520000,"shareType":"SH","priorValue":105722800,"priorShares":4520000},{"issuer":"TANGO THERAPEUTICS INC","titleOfClass":"COM","cusip":"87583X109","value":130998500,"shares":4190611,"shareType":"SH","priorValue":86751328,"priorShares":4146813},{"issuer":"ADAPTHEALTH CORP","titleOfClass":"COMMON STOCK","cusip":"00653Q102","value":119597947,"shares":11477730,"shareType":"SH","priorValue":136584987,"priorShares":11477730},{"issuer":"PHARVARIS N V","titleOfClass":"COM","cusip":"N69605108","value":116743532,"shares":3376042,"shareType":"SH","priorValue":88310687,"priorShares":3126042},{"issuer":"CELCUITY INC","titleOfClass":"NOTE 0.250% 8/0","cusip":"15102KAB6","value":113779900,"shares":100000000,"shareType":"PRN"},{"issuer":"ARROWHEAD PHARMACEUTICALS IN","titleOfClass":"COM","cusip":"04280A100","value":113221873,"shares":1389055,"shareType":"SH","priorValue":98645722,"priorShares":1573297},{"issuer":"DIANTHUS THERAPEUTICS INC","titleOfClass":"COM","cusip":"252828108","value":109695511,"shares":1125313,"shareType":"SH","priorValue":85582707,"priorShares":1019813},{"issuer":"LARIMAR THERAPEUTICS INC","titleOfClass":"COM","cusip":"517125100","value":108601271,"shares":35606974,"shareType":"SH","priorValue":160231383,"priorShares":35606974},{"issuer":"MINERALYS THERAPEUTICS INC","titleOfClass":"COM","cusip":"603170101","value":106786840,"shares":3958000,"shareType":"SH"},{"issuer":"ALIGNMENT HEALTHCARE INC","titleOfClass":"NOTE   4.250%11/1","cusip":"01625VAB0","value":103829930,"shares":61000000,"shareType":"PRN","priorValue":85858720,"priorShares":61000000},{"issuer":"IDEAYA BIOSCIENCES INC","titleOfClass":"COM","cusip":"45166A102","value":101169527,"shares":2714503,"shareType":"SH","priorValue":50979867,"priorShares":1530008},{"issuer":"XENON PHARMACEUTICALS INC","titleOfClass":"COM","cusip":"98420N105","value":97523411,"shares":1615696,"shareType":"SH","priorValue":93952722,"priorShares":1615696},{"issuer":"IONIS PHARMACEUTICALS INC","titleOfClass":"NOTE   1.750% 6/1","cusip":"462222AF7","value":93104400,"shares":60000000,"shareType":"PRN","priorValue":90613860,"priorShares":60000000},{"issuer":"SAVARA INC","titleOfClass":"COM","cusip":"805111101","value":83585040,"shares":13569000,"shareType":"SH","priorValue":74086740,"priorShares":13569000},{"issuer":"LANTHEUS HLDGS INC","titleOfClass":"COM","cusip":"516544103","value":83537709,"shares":752999,"shareType":"SH","priorValue":62803724,"priorShares":827999},{"issuer":"SYNDAX PHARMACEUTICALS INC","titleOfClass":"COM","cusip":"87164F105","value":82628614,"shares":3779900,"shareType":"SH","priorValue":88298464,"priorShares":3779900},{"issuer":"ZENAS BIOPHARMA INC","titleOfClass":"NOTE   2.500% 4/0","cusip":"98937LAA3","value":80316096,"shares":67200000,"shareType":"PRN","priorValue":67252900,"priorShares":65000000},{"issuer":"BIOMARIN PHARMACEUTICAL INC","titleOfClass":"COM","cusip":"09061G101","value":76264876,"shares":1332836,"shareType":"SH","priorValue":48104398,"priorShares":851556},{"issuer":"PFIZER INC","titleOfClass":"COM","cusip":"717081103","value":73203200,"shares":3040000,"shareType":"SH","priorValue":85363200,"priorShares":3040000},{"issuer":"INDIVIOR PHARMACEUTICALS INC","titleOfClass":"COM","cusip":"45579U109","value":67654162,"shares":1648895,"shareType":"SH","priorValue":94420639,"priorShares":3097790},{"issuer":"BIO RAD LABS INC","titleOfClass":"CL A","cusip":"090572207","value":66376413,"shares":226070,"shareType":"SH","priorValue":63017013,"priorShares":226070},{"issuer":"ARS PHARMACEUTICALS INC","titleOfClass":"COM","cusip":"82835W108","value":60105534,"shares":7503812,"shareType":"SH","priorValue":60255610,"priorShares":7503812},{"issuer":"STOKE THERAPEUTICS INC","titleOfClass":"COM","cusip":"86150R107","value":59664920,"shares":1823500,"shareType":"SH","priorValue":59373160,"priorShares":1823500},{"issuer":"STRUCTURE THERAPEUTICS INC","titleOfClass":"SPONSORED ADS","cusip":"86366E106","value":58285620,"shares":1086000,"shareType":"SH","priorValue":37017263,"priorShares":767993},{"issuer":"ENVISTA HOLDINGS CORPORATION","titleOfClass":"COM","cusip":"29415F104","value":58236135,"shares":2210100,"shareType":"SH","priorValue":56070237,"priorShares":2210100},{"issuer":"INSPIRE MED SYS INC","titleOfClass":"COM","cusip":"457730109","value":57853014,"shares":1296862,"shareType":"SH","priorValue":139433016,"priorShares":2703238},{"issuer":"CAREDX INC","titleOfClass":"COM","cusip":"14167L103","value":56932113,"shares":1997618,"shareType":"SH","priorValue":38035760,"priorShares":2191000},{"issuer":"BOSTON SCIENTIFIC CORP","titleOfClass":"COM","cusip":"101137107","value":56124200,"shares":1315000,"shareType":"SH"},{"issuer":"BELITE BIO INC","titleOfClass":"SPONSORED ADS","cusip":"07782B104","value":55003288,"shares":357199,"shareType":"SH","priorValue":48471833,"priorShares":304013},{"issuer":"PARABILIS MEDICINES INC","titleOfClass":"COM","cusip":"698955101","value":51474868,"shares":1880704,"shareType":"SH"},{"issuer":"CERTARA INC","titleOfClass":"COM","cusip":"15687V109","value":49209678,"shares":7512928,"shareType":"SH","priorValue":44509049,"priorShares":7808605},{"issuer":"DISC MEDICINE INC","titleOfClass":"COM","cusip":"254604101","value":48052980,"shares":657000,"shareType":"SH","priorValue":42008580,"priorShares":657000},{"issuer":"LIVANOVA PLC","titleOfClass":"NOTE   2.500% 3/1","cusip":"53802LAB8","value":46485120,"shares":34280000,"shareType":"PRN","priorValue":40033281,"priorShares":34280000},{"issuer":"BRIDGEBIO ONCOLOGY THERAPEUT","titleOfClass":"COM NEW","cusip":"107924102","value":37227099,"shares":4885446,"shareType":"SH","priorValue":43724742,"priorShares":4885446},{"issuer":"TYRA BIOSCIENCES INC","titleOfClass":"COM","cusip":"90240B106","value":32482980,"shares":1017000,"shareType":"SH","priorValue":21026700,"priorShares":549000},{"issuer":"MONOPAR THERAPEUTICS INC","titleOfClass":"COM NEW","cusip":"61023L207","value":29975550,"shares":323745,"shareType":"SH","priorValue":17737989,"priorShares":323745},{"issuer":"SIONNA THERAPEUTICS INC","titleOfClass":"COM","cusip":"829401108","value":29953495,"shares":680916,"shareType":"SH","priorValue":38910953,"priorShares":970590},{"issuer":"IMMUNOCORE HLDGS PLC","titleOfClass":"NOTE   2.500% 2/0","cusip":"45258DAB1","value":27104340,"shares":30000000,"shareType":"PRN","priorValue":27025200,"priorShares":30000000},{"issuer":"AVALYN PHARMACEUTICALS INC","titleOfClass":"COM SHS","cusip":"05348Y105","value":24064520,"shares":731000,"shareType":"SH"},{"issuer":"FOGHORN THERAPEUTICS INC","titleOfClass":"COM","cusip":"344174107","value":21444511,"shares":4394367,"shareType":"SH","priorValue":21005074,"priorShares":4394367},{"issuer":"BETA BIONICS INC","titleOfClass":"COM","cusip":"08659B102","value":20747080,"shares":1324000,"shareType":"SH","priorValue":13266480,"priorShares":1324000},{"issuer":"ALNYLAM PHARMACEUTICALS INC","titleOfClass":"COM","cusip":"02043Q107","value":20450473,"shares":67935,"shareType":"SH","priorValue":22477653,"priorShares":67935},{"issuer":"BRIGHT MINDS BIOSCIENCES INC","titleOfClass":"COM NEW","cusip":"10919W405","value":19866600,"shares":283000,"shareType":"SH","priorValue":20650510,"priorShares":283000},{"issuer":"ODYSSEY THERAPEUTICS INC","titleOfClass":"COMMON STOCK","cusip":"67613T104","value":19573261,"shares":1046139,"shareType":"SH"},{"issuer":"THE ONCOLOGY INSTITUTE INC","titleOfClass":"COM","cusip":"68236X100","value":18245082,"shares":3360052,"shareType":"SH","priorValue":10315360,"priorShares":3360052},{"issuer":"KYVERNA THERAPEUTICS INC","titleOfClass":"COM","cusip":"501976104","value":17820000,"shares":2000000,"shareType":"SH","priorValue":17260000,"priorShares":2000000},{"issuer":"ALAMAR BIOSCIENCES INC","titleOfClass":"COMMON STOCK","cusip":"010911105","value":16254000,"shares":600000,"shareType":"SH"},{"issuer":"CHEMED CORP NEW","titleOfClass":"COM","cusip":"16359R103","value":13972200,"shares":30000,"shareType":"SH"},{"issuer":"SPYGLASS PHARMA INC","titleOfClass":"COM SHS","cusip":"85220G109","value":12243000,"shares":550000,"shareType":"SH","priorValue":14250500,"priorShares":550000},{"issuer":"NEOGENOMICS INC","titleOfClass":"NOTE   0.250% 1/1","cusip":"64049MAB6","value":12202076,"shares":13040000,"shareType":"PRN","priorValue":66653778,"priorShares":72689000},{"issuer":"ADAGENE INC","titleOfClass":"ADS","cusip":"005329107","value":11199997,"shares":2666666,"shareType":"SH"},{"issuer":"HEMAB THERAPEUTICS HLDGS INC","titleOfClass":"COM SHS","cusip":"423494103","value":10100750,"shares":275000,"shareType":"SH"},{"issuer":"MOBIA MED INC","titleOfClass":"COMMON STOCK","cusip":"60705V103","value":8988077,"shares":670752,"shareType":"SH"},{"issuer":"EMBECTA CORP","titleOfClass":"COMMON STOCK","cusip":"29082K105","value":8263973,"shares":2534961,"shareType":"SH","priorValue":22409055,"priorShares":2534961},{"issuer":"VERACYTE INC","titleOfClass":"COM","cusip":"92337F107","value":5931730,"shares":101000,"shareType":"SH","priorValue":23384460,"priorShares":726000},{"issuer":"ANNEXON INC","titleOfClass":"COM","cusip":"03589W102","value":3334143,"shares":583913,"shareType":"SH","priorValue":3234878,"priorShares":583913},{"issuer":"ALECTOR INC","titleOfClass":"COM","cusip":"014442107","value":2120936,"shares":1055192,"shareType":"SH","priorValue":2268663,"priorShares":1055192},{"issuer":"NEWAMSTERDAM PHARMA COMPANY","titleOfClass":"*W EXP 99/99/999","cusip":"N62509117","value":1982858,"shares":92787,"shareType":"SH","priorValue":1859451,"priorShares":92787},{"issuer":"EDWARDS LIFESCIENCES CORP","titleOfClass":"COM","cusip":"28176E108","value":1239483,"shares":13702,"shareType":"SH","priorValue":1097256,"priorShares":13702},{"issuer":"MIRUM PHARMACEUTICALS INC","titleOfClass":"COM","cusip":"604749101","value":705581,"shares":6027,"shareType":"SH"},{"issuer":"HUMANA INC","titleOfClass":"COM","cusip":"444859102","value":364251,"shares":917,"shareType":"SH","priorValue":158999,"priorShares":917},{"issuer":"THE ONCOLOGY INSTITUTE INC","titleOfClass":"*W EXP 99/99/999","cusip":"68236X118","value":51000,"shares":1250000,"shareType":"SH","priorValue":54750,"priorShares":1250000},{"issuer":"PMV PHARMACEUTICALS INC","titleOfClass":"COM","cusip":"69353Y103","value":11779,"shares":8790,"shareType":"SH","priorValue":10900,"priorShares":8790},{"issuer":"SURROZEN INC","titleOfClass":"*W EXP 08/01/203","cusip":"86889P117","value":2750,"shares":166666,"shareType":"SH","priorValue":2667,"priorShares":166666}]},"notice":"Compiled from public SEC Form ADV filings on the dates in `sources`. Facts as filed; not a rating, ranking, or recommendation. Niva Wealth is not affiliated with this firm. Disciplinary history is deliberately not included here or on the page; the SEC publishes the complete record at the `iapdUrl` above."}